|本期目录/Table of Contents|

 YU Yanfang,LIU Yanhong,HUO Meirong.Application of nanocarriers for oral delivery of anticancer drugs[J].Chinese Journal of Bioprocess Engineering,2018,16(05):64-70.[doi:10.3969/j.issn.1672-3678.2018.05.009]





Application of nanocarriers for oral delivery of anticancer drugs
1.南京工业大学 生物与制药工程学院,江苏 南京 211800; 2.中国药科大学 药学院,江苏 南京 210009
YU Yanfang1LIU Yanhong2HUO Meirong2
1.College of Biotechnology and Pharmaceutical Engineering,Nanjing Tech University,Nanjing 211800,China; 2.School of Pharmacy,China Pharmaceutical University,Nanjing 210009,China
纳米药物递送系统 口服递送 抗癌药物 生理病理屏障 P-糖蛋白 生物材料


[1] ZHANG H,DOU J,ZHAI Y,et al.Advances in the formulations of non-injection administration of docetaxel[J].J Drug Targeting,2014,22(2):87-94.
[2] KOOLEN S L,BEIJNEN J H,SCHELLENS J H.Intravenous-to-oral switch in anticancer chemotherapy:a focus on docetaxel and paclitaxel[J].Clin Pharm Ther,2010,87(1):126-129.
[3] GRIFFIN B T,GUO J,PRESAS E,et al.Pharmacokinetic,pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs[J].Adv Drug Deliv Rev,2016,106:367-380.
[4] Sohail M F,Rehman M,Sarwar H S,et al.Advancements in the oral delivery of Docetaxel:challenges,current state-of-the-art and future trends.[J].Int J Nanomed,2018,13:3145-3161.
[5] CHOUDHURY H,GORAIN B,TEKADE R K,et al.Safety against nephrotoxicity in paclitaxel treatment:oral nanocarrier as an effective tool in preclinical evaluation with marked in vivo antitumor activity[J].Regul Toxicol pharmacol:2017,91:179-189.
[6] THANKI K,GANGWAL R P,SANGAMWAR A T,et al.Oral delivery of anticancer drugs:challenges and opportunities[J].J Control Release,2013,170(1):15-40.
[7] ARAJO F,DAS NEVES J,MARTINS J P,et al.Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals[J].Prog Mater Sci,2017,89:306-344.
[8] FUHRMANN K,FUHRMANN G.Recent advances in oral delivery of macromolecular drugs and benefits of polymer conjugation[J].Curr Opin Colloid Interface Sci,2017,31:67-74.
[9] 徐鹏程.纳米技术在口服给药系统中的应用[J].内蒙古科技与经济,2016(10):80.
[10] SHIMIZU K.Development of new liposome targeting strategies for application of disease therapies[J].Yakugaku Zasshi:J Pharm Soc Japan,2017,137(1):43-48.
[11] ADEOYE O,CABRAL-MARQUES H.Cyclodextrin nanosystems in oral drug delivery:a mini review[J].Int J Pharm,2017,531(2):521-531.
[12] FAN W,ZHANG L,LI Y,et al.Recent progress of crosslinking strategies for polymeric micelles with enhanced drug delivery in cancer therapy[J].Curr Med Chem,1969,doi:10.2174/0929867324666171121102255.
[13] REHMAN M,IHSAN A,MADNI A,et al.Solid lipid nanoparticles for thermoresponsive targeting:evidence from spectrophotometry,electrochemical,and cytotoxicity studies[J].Int J Nanomed,2017,12:8325-8336.
[14] SUN J,LIU Y,GE M,et al.A Distinct endocytic mechanism of functionalized-silica nanoparticles in breast cancer stem cells[J].Sci Rep,2017,doi:10.1038/s41598-017-16591-z.
[15] MOHAMMED M A,SYEDA J T M,WASAN K M,et al.An Overview of chitosan nanoparticles and its application in non-parenteral drug delivery[J].Pharmaceutics,2017,doi:10.3390/pharmaceutics9040053.
[16] Kang X,Chen H,Li S,et al.Magnesium lithospermate B loaded PEGylated solid lipid nanoparticles for improved oral bioavailability[J].Colloids Surface B,2017,161:597-605.
[17] MEI L,ZHANG Z,ZHAO L,et al.Pharmaceutical nanotechnology for oral delivery of anticancer drugs[J].Adv Drug Deliv Rev,2013,65(6):880-890.
[18] Jain A K,JAIN S.Advances in oral delivery of anti-cancer prodrugs[J].Expert Opin Drug Deliv,2016,13(12):1759-1775.
[19] GEDAWY A,MARTINEZ J,AL-SALAMI H,et al.Oral insulin delivery:existing barriers and current counter-strategies[J].J Pharm Pharmacol,2017,70(2):197-213.
[20] 杨晖,姚静,周建平.针对胃肠道黏液屏障的口服纳米粒研究进展[J].药学与临床研究,2012,20(4):339-342.
[21] KARLSSON J,WIKMAN A,ARTURSSON P.The mucus layer as a barrier to drug absorption in monolayers of human intestinal epithelial HT29-H goblet cells[J].Int J Pharma,1993,99(2/3):209-218.
[22] Date A A,Hanes J,Ensign L M.Nanoparticles for oral delivery:design,evaluation and state-of-the-art[J].J Control Release,2016,240:504-526.
[23] PAWAR V K,MEHER J G,SINGH Y,et al.Targeting of gastrointestinal tract for amended delivery of proteins/peptides therapeutics:strategies and industrial perspectives[J].J Control Release,2014,196:168-183.
[24] KRISTENSEN M,NIELSEN H M.Cell-penetrating peptides as carriers for oral delivery of biopharmaceuticals[J].Basic Clin Pharmacol Toxicol,2016,118(2):99-106.
[25] WANG F,ZHANG D,ZHANG Q,et al.Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel-polymer micelles to overcome multi-drug resistance[J].Biomaterials,2011,32(35):9444-9456.
[26] HULS M,RUSSEL F G M,MASEREEUW R.The role of ABC transporters in tissue defense and organ regeneration[J].J Pharmacol Exp Ther,2008,328(1):3-9.
[27] GAO L,WANG X,MA J,et al.Evaluation of TPGS-modified thermo-sensitive Pluronic PF127 hydrogel as a potential carrier to reverse the resistance of P-gp-overexpressing SMMC-7721 cell lines[J].Colloids Surfaces B,2016,140:307-316.
[28] WANG J,SUN J,CHEN Q,et al.Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance[J].Biomaterials,2012,33(28):6877-6888.
[29] WAN C P,LETCHFORD K,JACKSON J K,et al.The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance[J].Int J Nanomed,2013,8:379-391.
[30] 徐巍,牟燕,李宏建.聚合物胶束提高难溶性药物生物利用度的研究进展[J].中国药房,2015(13):1847-1850.
[31] HOU J,SUN E,ZHANG Z H,et al.Improved oral absorption and anti-lung cancer activity of paclitaxel-loaded mixed micelles[J].Drug Deliv,2017,24(1):261-269.
[32] CHEN M C,MI F L,LIAO Z X,et al.Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules[J].Adv Drug Deliv Rev,2013,65(6):865-879.
[33] 管庆霞,高远,李永吉.pH敏感性材料在口服给药系统中的研究[J].哈尔滨商业大学学报(自然科学版),2013,29(2):133-137.
[34] LI J,HUANG P,CHANG L,et al.Tumor targeting and pH-responsive polyelectrolyte complex nanoparticles based on hyaluronic acid-paclitaxel conjugates and chitosan for oral delivery of paclitaxel[J].Macromol Res,2013,21(12):1331-1337.
[35] WANG Q,LI C,REN T,et al.Poly(vinyl methyl ether/maleic anhydride)-doped PEG-PLA nanoparticles for oral paclitaxel delivery to improve bioadhesive efficiency[J].Mol Pharm,2017,14(10):3598-3608.
[36] SUH J W,LEE J S,KO S,et al.Preparation and characterization of mucoadhesive buccal nanoparticles using chitosan and dextran sulfate[J].J Agric Food Chem,2016,64(26):5384-5388.
[37] SILVA D S,ALMEIDA A,PREZOTTI F G,et al.Self-aggregates of 3,6-O,O’-dimyristoylchitosan derivative are effective in enhancing the solubility and intestinal permeability of camptothecin[J].Carbohydr Polym,2017,177:178-186.
[38] LV P P,WEI W,YUE H,et al.Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration[J].Biomacromolecules,2011,12(12):4230-4239.
[39] WERLE M,BERNKOP-SCHNURCH A.Thiolated chitosans:useful excipients for oral drug delivery[J].J Pharm Pharmacol,2008,60(3):273-281.
[40] SIDDHARTH S,NAYAK A,NAYAK D,et al.Chitosan-dextran sulfate coated doxorubicin loaded PLGA-PVA-nanoparticles caused apoptosis in doxorubicin resistance breast cancer cells through induction of DNA damage[J].Sci Rep,2017,7(1):2143.
[41] LIAN H,ZHANG T,SUN J,et al.Enhanced oral delivery of paclitaxel using acetylcysteine functionalized chitosan-vitamin E succinate nanomicelles based on a mucus bioadhesion and penetration mechanism[J].Mol Pharm,2013,10(9):3447-3458.
[42] HUO M,FU Y,LIU Y,et al.N-mercapto acetyl-N’-octyl-O,N″-glycol chitosan as an efficiency oral delivery system of paclitaxel[J].Carbohydr Polym,2018,181:477-488.[43] NGUYEN T X,HUANG L,GAUTHIER M,et al.Recent advances in liposome surface modification for oral drug delivery[J].Nanomedicine,2016,11(9):1169-1185.
[44] JAIN S,KUMAR D,SWARNAKAR N K,et al.Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel[J].Biomaterials,2012,33(28):6758-6768.
[45] WANG Q,WEI Q,YANG Q.A novel formulation of [6] -gingerol:proliposomes with enhanced oral bioavailability and antitumor effect[J].Int J Pharm,2018,535(1/2):308-315.
[46] WU J,LIU Q,LEE R J.A folate receptor-targeted liposomal formulation for paclitaxel[J].Int J Pharm,2006,316(1/2):148-153.
[47] TAKEUCHI H,YAMAMOTO H,NIWA T,et al.Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes[J].Pharm Res,1996,13(6):896-901.
[48] YANG M,LAI S K,WANG Y Y,et al.Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus[J].Angew Chem Int Ed,2011,50(11):2597-2600.
[49] CHEN D,XIA D,LI X,et al.Comparative study of Pluronic F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats[J].Int J Pharm,2013,449(1/2):1-9.
[50] DIAB R,CANILHO N,PAVEL I A.,et al.Silica-based systems for oral delivery of drugs,macromolecules and cells[J].Adv Colloid Interface Sci,2017,249:346-362.
[51] TIAN B,LIU S,WU S,et al.pH-responsive poly(acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin[J].Colloids Surfaces B,2017,154:287-296.
[52] WANG Y,ZHAO Y,CUI Y,et al.Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers[J].Acta Biomater,2018,65:405-416.
[53] GHOLIPOURMALEKABADI M,MOBARAKI M,GHAFFARI M,et al.Targeted drug delivery based on gold nanoparticle derivatives[J].Curr Pharm Design,2017,23(20):2918-2929.
[54] DHESINGH R S,THAMBIRAJ S,HEMA S.An overview on applications of gold nanoparticle for early diagnosis and targeted drug delivery to prostate cancer[J].Recent Patents Nanotech,2017,12(2):110-131.
[55] CHEN Y,XU M,GUO Y,et al.Targeted chimera delivery to ovarian cancer cells by heterogeneous gold magnetic nanoparticle[J].Nanotechnology,2017,28(2):025101.
[56] KANG S H,REVURI V,LEE S J,et al.Oral siRNA delivery to treat colorectal liver metastases[J].ACS Nano,2017,11(10):10417-10429.


作者简介:于艳芳(1974—),女,山东文登人,博士,工程师,研究方向:新型给药系统; 霍美蓉(联系人),教授,E-mail:huomeirongcpu@163.com
YU Yanfang,LIU Yanhong,HUO Meirong.Application of nanocarriers for oral delivery of anticancer drugs [J].Chin J Bioprocess Eng,2018,16(5):64-70..
更新日期/Last Update: 2018-09-30